VCM
NPCE icon

Versant Capital Management’s Neuropace NPCE Stock Holding History

Versant Capital Management’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$763 Buy
+48
New +$772 ﹤0.01% 2672

Other funds holding NPCE

FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
HFS
Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Versant Capital Management's NPCE Position: Q2 2026 in Review

Versant Capital Management opened a new position in Neuropace (NPCE) in Q2 2026: 48 shares worth $763. The stake represents ﹤0.01% of the portfolio and ranks #2672 among its holdings.

4 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Versant Capital Management held 48 shares of Neuropace worth $763 as of Q2 2026.
  • Neuropace was a new Versant Capital Management position in Q2 2026.
  • Neuropace made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2672 holding.
  • 4 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.